| Cases | Controls | n | P value |
---|---|---|---|---|
Total, n | 1,136 | 1,791 | 2,927 | Â |
Age, years | 62.2 ± 5.1 | 61.6 ± 5.2 | 2,927 | 0.003 |
PSA, ng/mL | 8.5 ± 15.4 | 1.1 ± 1.3 | 2,925 | <0.001 |
Gleason grade, % (<7/≥7) | 70.0/30.0 | n/a | 1,135 |  |
TNM stage, % (localized/advanced) | 88.4/11.6 | n/a | 1,136 | Â |
BPH, % (no/yes)a | 92.7/7.3 | 89.0/11.0 | 1,363 | 0.02 |
BMI, kg/m2 | 27.0 ± 3.7 | 27.5 ± 4.1 | 1,973 | 0.01 |
Height, cm | 176.4 ± 7.0 | 175.9 ± 6.9 | 2,078 | 0.2 |
Weight, kg | 84.5 ± 13.0 | 85.9 ± 14.6 | 2,677 | 0.02 |
leg length, cm | 76.7 ± 4.8 | 76.5 ± 4.6 | 2,055 | 0.3 |
Birthweight, g | 3,437.2 ± 744.9 | 3,476.1 ± 663.4 | 939 | 0.4 |
Family history, % (no/yes)b | 92.7/7.3 | 95.0/5.0 | 2,908 | 0.01 |
Diabetes, % (no/yes)c | 92.8/7.2 | 91.1/8.9 | 1,895 | 0.2 |
IGF-I, ng/mL | 156.1 ± 55.8 | 163.2 ± 57.0 | 1,756 | 0.01 |
IGF-II, ng/mL | 862.1 ± 323.6 | 733.7 ± 265.3 | 1,720 | <0.001 |
IGFBP-2, ng/mL | 731.5 ± 426.0 | 726.2 ± 444.7 | 1,745 | 0.5d |
IGFBP-3, ng/mL | 4,673.6 ± 1,041.9 | 4,370.8 ± 1,055.7 | 1,711 | <0.001 |
IGF-I:IGFBP-3 molar ratioe | 0.12 ± 0.04 | 0.14 ± 0.06 | 1,711 | <0.001d |